11.4 Local & General Anesthetic Pharmacology

11.4 Local & General Anesthetic Pharmacology

Independent Study Guide Notice: Independent study guide by OpenExamPrep. This educational resource is developed independently by OpenExamPrep and is not sponsored, endorsed, or affiliated with the National Board of Podiatric Medical Examiners (NBPME) or Meazure Learning.

---

Mechanism of Action: Voltage-Gated Sodium Channel Blockade

Local anesthetics (LAs) prevent the generation and conduction of nerve impulses throughout the peripheral nervous system. Their primary molecular target is the voltage-gated sodium channel ($Na_V$) situated along the axonal plasma membrane (axolemma).

The Intracellular Binding Site & State-Dependent Block

1. Intracellular Access: Local anesthetics exist in an aqueous equilibrium between an uncharged lipophilic free base ($B$) and a charged protonated cation ($BH^+$). The uncharged base $B$ is the only form capable of diffusing across the hydrophobic perineural sheath and lipid bilayer axonal membrane. Once inside the neutral/slightly acidic axoplasm (pH $\approx 7.2$), the free base picks up a hydrogen ion to re-equilibrate into the charged cation ($BH^+$).
2. Channel Receptor Binding: The charged cation $BH^+$ binds with high affinity to a specific receptor site located on the intracellular vestibule (pore) of the $Na_V$ channel (specifically targeting the S6 segments of domains I, III, and IV). Once bound, it physically plugs the channel pore, preventing sodium ion ($Na^+$) influx.
3. Electrophysiological Cascade: With sodium entry blocked, the nerve membrane cannot achieve threshold potential; the rate of depolarization drops to zero, action potential generation and propagation cease, and sensory nociceptive signals cannot reach the spinal cord.
4. Use-Dependent (State-Dependent) Blockade: Voltage-gated sodium channels cycle through three distinct conformations:
   • Resting (Closed): Polarized membrane; channel closed, ready to open.
   • Activated (Open): Depolarized membrane; channel open, admitting $Na^+$.
   • Inactivated (Closed/Refractory): Depolarized; channel blocked by intracellular inactivation loop. Local anesthetics possess much higher binding affinity for channels in the activated (open) and inactivated states than in the resting state. Consequently, nerve axons that are firing repetitively at high frequency (such as sensory fibers transmitting acute surgical or nociceptive pain) are blocked much more rapidly and deeply than quiescent resting fibers (frequency-dependent or use-dependent block).

                        Axonal Local Anesthetic Permeation
    
          Extracellular Fluid                      Axoplasm
          ───────────────────                      ────────
           BH+  (Charged, 75%)
            ▲
            │ (pH 7.4)
            ▼
            B   (Uncharged Base, 25%) ──► [Diffuses across Axolemma]
                                                      │
                                                      ▼
                                              B   (Uncharged Base)
                                                      ▲
                                                      │ (Axoplasm pH 7.2)
                                                      ▼
                                              BH+ (Charged Cation)
                                                      │
                                                      ▼
                                            [Binds Intracellular Pore of
                                              Voltage-Gated Na+ Channel]
                                                      │
                                                      ▼
                                            Halts Na+ Influx & Conduction

---

Differential Susceptibility of Nerve Fibers

Peripheral nerves are composed of distinct fiber types differing in diameter, conduction velocity, and presence of a myelin sheath. Local anesthetic blockade does not occur simultaneously across all modalities; rather, it follows a predictable, highly reproducible physiological sequence governed by fiber diameter and myelination:

Chemical Structure, Classification & Metabolism

Every local anesthetic molecule consists of three distinct chemical domains:

1. Lipophilic Aromatic Ring: (Typically a benzene ring); confers lipid solubility and governs membrane penetration.
2. Intermediate Hydrocarbon Chain: Contains either an Ester linkage ($-COO-$) or an Amide linkage ($-NH-CO-$). Determines the pathway of biotransformation and allergic potential.
3. Hydrophilic Tertiary Amine: Acts as a proton acceptor; allows formulation as a water-soluble hydrochloride salt for parenteral injection.

                         Chemical Architecture of Local Anesthetics
    
      [Lipophilic Ring] ────── [Intermediate Linkage] ────── [Hydrophilic Amine]
        (Benzene core)          (Ester or Amide chain)        (Tertiary amine, pKa 7.6-8.9)
              │                            │                               │
              ▼                            ▼                               ▼
       Lipid Solubility            Metabolic Pathway               Water Solubility
       (Potency)                   (Pseudocholinesterase           (On/Off Protonation)
                                    vs. Hepatic CYP450)

The Mnemonic Rule for Amides vs. Esters

• Amides contain TWO "i"s in their generic names: Lidocaine, Bupivacaine, Ropivacaine, Mepivacaine, Prilocaine, Etidocaine, Articaine (articaine contains an amide linkage but also possesses an ester side-ring, yielding rapid hybrid clearance).
• Esters contain ONE "i" in their generic names: Procaine (Novocain), Tetracaine, Cocaine, Chloroprocaine, Benzocaine.

Metabolism & Allergic Hypersensitivity

• Ester Local Anesthetics: Rapidly metabolized in the bloodstream and tissues by plasma pseudocholinesterase (butyrylcholinesterase) via hydrolysis. Hydrolysis generates para-aminobenzoic acid (PABA).
  • Allergy Pearl: PABA is a potent immunological hapten capable of triggering true Type I IgE-mediated anaphylaxis and Type IV contact dermatitis. True allergic reactions to ester local anesthetics are well-documented.
  • Ester metabolism is markedly prolonged in patients with inherited pseudocholinesterase deficiency (atypical pseudocholinesterase).
• Amide Local Anesthetics: Metabolized primarily in the liver by microsomal Cytochrome P450 enzymes (CYP1A2, CYP3A4) via N-dealkylation and hydroxylation. Elimination half-life is significantly prolonged in patients with hepatic cirrhosis, hypothermia, or congestive heart failure (decreased hepatic blood flow).
  • Allergy Pearl: True IgE-mediated allergic reactions to amide local anesthetics are extraordinarily rare ($<1\%$). The vast majority of reported adverse events represent vasovagal syncope, accidental intravascular epinephrine response (palpitations, anxiety, diaphoresis), or hypersensitivity to methylparaben, an antimicrobial preservative historically added to multi-dose vials (structurally similar to PABA). Single-dose preservative-free amide vials eliminate this risk.

---

Physicochemical Determinants of Clinical Performance

Three physicochemical properties dictate the onset, potency, and duration of action of local anesthetics:

Clinical Board Pearl: The Infected Acidic Foot Microenvironment

Local anesthetics are weak bases with $pK_a$ values ranging from $7.6$ to $8.9$. At normal physiologic subcutaneous pH ($7.4$), approximately $20\% - 25\%$ of lidocaine exists as the uncharged, membrane-permeable free base ($B$):

$7.4 - 7.9 = -0.5 \implies \frac{[B]}{[BH^+]} = 10^{-0.5} \approx 0.316 \implies \sim 24\% \text{ free base } B$

---

Maximum Dosages & Clinical Formulations

Calculating maximum safe dosages based on patient weight is critical to prevent fatal systemic toxicity during foot and ankle procedures:

The Concentration Conversion Rule

A $1\%$ solution contains $1\text{ g}$ of solute per $100\text{ mL}$ of water = $1,000\text{ mg} / 100\text{ mL} = \mathbf{10\text{ mg/mL}}$.

• $0.5\% \text{ Bupivacaine} = \mathbf{5\text{ mg/mL}}$
• $0.25\% \text{ Bupivacaine} = \mathbf{2.5\text{ mg/mL}}$
• $2\% \text{ Lidocaine} = \mathbf{20\text{ mg/mL}}$

Role of Additives in Podiatric Infiltration

1. Epinephrine (Vasoconstrictor, 1:100,000 or 1:200,000):
   • Stimulates vascular $\alpha_1$-adrenergic receptors, producing local arteriolar constriction.
   • Four Major Clinical Benefits:
     1. Decreases local blood flow, dramatically slowing vascular absorption of the anesthetic into systemic circulation.
     2. Prolongs duration of sensory blockade by $50\% - 100\%$.
     3. Reduces peak plasma drug concentration ($C_{\max}$) by $\sim 30\%$, significantly lowering systemic toxicity risk and permitting higher maximum safe doses.
     4. Improves local surgical hemostasis in the operative field.
   • High-Yield Precautions: Exercise extreme caution in patients with severe Peripheral Arterial Disease (PAD), end-stage vasospastic disorders (Raynaud's phenomenon, thromboangiitis obliterans), or digital blocks in severely compromised toes where vasoconstriction could precipitate irreversible ischemic gangrene.
2. Sodium Bicarbonate ($NaHCO_3$ Buffering):
   • Standard formulation: $1\text{ mL}$ of $8.4\%$ $NaHCO_3$ per $9 - 10\text{ mL}$ of local anesthetic (1:10 ratio with 1% lidocaine).
   • Rationale: Commercial local anesthetic solutions are packaged at an acidic pH ($4.5 - 5.5$; pH $3.5 - 4.5$ if co-formulated with epinephrine to prevent auto-oxidation of the catecholamine). Injecting this acidic fluid causes intense burning and stinging.
   • Dual Effects of Buffering:
     1. Accelerates Speed of Onset: Neutralizes the solution to pH $\sim 7.35$, dramatically increasing the fraction of uncharged lipophilic base ($B$) available to diffuse across the axolemma.
     2. Significantly Reduces Injection Pain: Diminishes the acute stinging pain caused by tissue acid nociceptor activation.

Severe Toxicities: LAST & Methemoglobinemia

Local Anesthetic Systemic Toxicity (LAST)

LAST is a life-threatening complication resulting from accidental direct intravascular injection or rapid systemic absorption of supratherapeutic doses.

Clinical Progression of LAST

1. Initial CNS Excitation: Signs appear within seconds to minutes. Patients experience perioral numbness and paresthesias, a distinctive metallic taste in the mouth, tinnitus (ringing in ears), lightheadedness, visual disturbances, slurred speech, tremors, and involuntary muscle twitching, culminating in generalized tonic-clonic seizures. (Mechanism: local anesthetics selectively inhibit inhibitory cortical interneurons, disinhibiting excitatory pathways).
2. CNS Depression: Massive global channel blockade causes rapid central depression: drowsiness, unconsciousness, coma, and complete respiratory arrest.
3. Cardiovascular (CV) Toxicity: Severe cardiac toxicity ensues: sinus bradycardia, prolonged PR and QRS intervals, atrioventricular dissociation, ventricular tachycardia, refractory ventricular fibrillation, profound hypotension, and asystole.

Bupivacaine Cardiotoxicity Pearl

Bupivacaine is substantially more cardiotoxic than lidocaine. Bupivacaine displays high avidity for cardiac voltage-gated sodium channels and dissociates extraordinarily slowly during diastole (the classic "fast-in, slow-out" kinetics). During normal heart rates, bupivacaine accumulates in cardiac sodium channels, severely depressing phase 0 depolarizing velocity ($V_{\max}$), triggering lethal re-entrant ventricular arrhythmias and electromechanical dissociation that are notoriously refractory to standard ACLS resuscitation.

Definitive LAST Management: The Lipid Rescue Protocol

When LAST is recognized, immediate multi-step intervention is mandatory:

1. Stop Injection Immediately & Call for Help: Alert surgical team and call for the LAST rescue kit containing $20\%$ lipid emulsion.
2. Airway Management: Administer $100\%\text{ }FiO_2$; hyperventilate to prevent hypoxia, hypercapnia, and metabolic acidosis (acidosis markedly worsens bupivacaine cardiotoxicity and lowers seizure thresholds).
3. Seizure Suppression: Administer intravenous Benzodiazepines (midazolam $1 - 2\text{ mg}$ IV); avoid propofol in hemodynamically unstable patients due to worsening myocardial depression.
4. Intravenous 20% Lipid Emulsion Therapy (LipidRescue):
   • Mechanism: Dual action: The "Lipid Sink" (creates an intravascular lipid partition that traps and sequesters lipophilic anesthetics like bupivacaine away from the myocardium and brain) + Metabolic Inotropy (directly overcomes bupivacaine-mediated inhibition of myocardial fatty acid beta-oxidation, providing immediate ATP substrate for the failing heart).
   • Dosing Algorithm:
     • Initial IV Bolus: $1.5\text{ mL/kg}$ (lean body weight) of $20\%$ Lipid Emulsion IV over 2–3 minutes; patients over 70 kg receive $100\text{ mL}$ (ASRA 2020 checklist).
     • Continuous Infusion: Immediately begin IV infusion at $0.25\text{ mL/kg/min}$ (for patients over 70 kg, 200–250 mL over 15–20 minutes).
     • Repeat bolus once or twice for persistent asystole; double infusion rate to $0.5\text{ mL/kg/min}$ if hypotension persists (maximum recommended cumulative dose $\approx 10 - 12\text{ mL/kg}$ over the first 30 minutes).
5. ACLS Modifications: Reduce epinephrine boluses to $<1\text{ mcg/kg}$ (high doses worsen arrhythmias and impair lipid rescue); AVOID vasopressin, calcium channel blockers, and beta-blockers.

Drug-Induced Methemoglobinemia

• Etiologic Agents: Exposure to Prilocaine (metabolized to o-toluidine) and topical Benzocaine (Hurricaine spray utilized for mucous membranes or wound debridement).
• Pathophysiology: Toxic oxidative metabolites oxidize the iron in hemoglobin from the normal ferrous state ($Fe^{2+}$) to the abnormal ferric state ($Fe^{3+}$), forming Methemoglobin ($MetHb$). Ferric heme cannot bind oxygen; furthermore, it alters the hemoglobin tetramer, shifting the oxygen-hemoglobin dissociation curve far to the left and preventing oxygen release to peripheral tissues (functional anemia and severe tissue hypoxia).
• Clinical Presentation: Central cyanosis refractory to supplemental $100\%\text{ }O_2$, headache, fatigue, tachypnea, and characteristic "chocolate-brown" or muddy-colored arterial blood that does not turn red upon exposure to room air.
• Pulse Oximetry Artefact: Standard pulse oximetry reads a falsely fixed saturation of $\sim 85\%$, regardless of actual oxygenation (because methemoglobin absorbs equal amounts of 660 nm and 940 nm light, yielding an optical ratio of 1.0, which corresponds algorithmically to $85\%$).
• Antidote: Intravenous Methylene Blue ($1 - 2\text{ mg/kg}$ IV over 5 minutes). Methylene blue acts as an electron acceptor and cofactor for NADPH-methemoglobin reductase, rapidly reducing ferric $Fe^{3+}$ back to ferrous $Fe^{2+}$.
  • High-Yield Contraindication: Methylene blue is strictly contraindicated in Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency because G6PD-deficient erythrocytes cannot generate NADPH, rendering methylene blue ineffective and triggering severe acute hemolytic anemia. It is also an MAOI and contraindicated with SSRIs.

---

Overview of General Anesthesia in Podiatric Surgery

Podiatric surgical procedures requiring general anesthesia utilize a combination of intravenous induction agents and volatile halogenated inhalational anesthetics to achieve the triad of unconsciousness, analgesia, and muscle relaxation:

Intravenous Induction & Sedative Agents

• Propofol (Diprivan): Allosteric agonist at $GABA_A$ receptors, increasing chloride conductance and hyperpolarizing neurons. Rapid onset ($30\text{ seconds}$) and fast recovery ($4 - 8\text{ minutes}$) via rapid redistribution from the vessel-rich brain to skeletal muscle and fat. Exhibits potent antiemetic properties. Causes marked arterial and venous vasodilation, producing profound hypotension and respiratory depression.
• Ketamine: Non-competitive antagonist at NMDA (N-methyl-D-aspartate) glutamate receptors. Produces dissociative anesthesia (eyes open, cataleptic state, profound somatic analgesia and amnesia). Indirectly stimulates the sympathetic nervous system, increasing heart rate, blood pressure, and cardiac output. Produces potent bronchodilation (ideal for severe asthmatics) while preserving airway reflexes and spontaneous respiratory drive. High-yield adverse effect: emergence delirium and vivid hallucinations (prevented by pre-treating with benzodiazepines).
• Etomidate: Modulates $GABA_A$ receptors; provides remarkable cardiovascular stability (minimal change in blood pressure, heart rate, or cardiac output; drug of choice for hemodynamically unstable or septic patients). High-yield adverse effect: transient adrenocortical suppression via reversible inhibition of $11\beta$-hydroxylase, halting cortisol and aldosterone synthesis.

Inhalational Anesthetics & Malignant Hyperthermia

• Minimum Alveolar Concentration (MAC): The alveolar concentration of an inhaled anesthetic at 1 atmosphere that prevents movement in $50\%$ of patients exposed to a noxious surgical stimulus. MAC is an inverse measure of anesthetic potency (lower MAC = higher lipid solubility = higher potency; Meyer-Overton rule). MAC values are strictly additive.
• Blood:Gas Partition Coefficient: Governs the speed of induction and emergence. Inversely related to the rate of rise of alveolar concentration to inspired concentration ($F_A/F_I$). Agents with a low blood:gas partition coefficient (e.g., Nitrous Oxide $= 0.47$, Desflurane $= 0.42$, Sevoflurane $= 0.65$) are poorly soluble in blood, rapidly saturating the vascular compartment to produce rapid induction and rapid emergence. Agents with high blood:gas solubility (Isoflurane $= 1.4$) have slower induction and recovery.